VolitionRx Limited Proceeds from Issuance of Warrants
VolitionRx Limited (VNRX) reported Proceeds from Issuance of Warrants of $1.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-13
- VolitionRx Limited proceeds from issuance of warrants for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- VolitionRx Limited proceeds from issuance of warrants for the quarter ending 2026-03-31 was $1.75M.
- VolitionRx Limited proceeds from issuance of warrants for the quarter ending 2025-12-31 was $28.58K.
- VolitionRx Limited proceeds from issuance of warrants for the quarter ending 2025-09-30 was -$28.60K.
- VolitionRx Limited proceeds from issuance of warrants for fiscal 2025 was $5.80M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.75M 10-Q · filed 2026-08-13 | $1.78M derived: sum of 3 quarters · filed 2026-08-13 | $1.75M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.75M 10-Q · filed 2026-05-14 | $1.78M derived: sum of 2 quarters · filed 2026-05-14 | $1.75M derived: sum of 3 quarters · filed 2026-05-14 | $7.56M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $28.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$20.00 derived: sum of 2 quarters · filed 2026-03-31 | $5.80M derived: sum of 3 quarters · filed 2026-08-13 | $5.80M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$28.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.77M derived: sum of 2 quarters · filed 2026-08-13 | $5.77M 10-Q · filed 2025-11-13 | $5.77M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.80M 10-Q · filed 2026-08-13 | $5.80M derived: sum of 3 quarters · filed 2026-08-13 | $5.80M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 10-Q · filed 2026-05-14 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |